Target intelligence / Profile preview

Tumor Cell Genomic DNA (DNA)

Target: DNA
Molecular classification: Nucleic Acid, DNA

Overview

Tumor cell genomic DNA serves as a central target for ionizing radiation therapy; its structural disruption via direct energy deposition and ROS generation underpins both the efficacy and selectivity seen clinically against malignant tissues.

Other names: Tumor DNACancer Cell DNAMalignant Cell DNA

Mechanism of action

Direct strand breakage & indirect ROS-mediated base/sugar/phosphate injury

Biological functions

Genome maintenanceReplicationTranscriptionCell proliferationGenetic information storage

Disease associations

CancerGenetic instability

Safety considerations

Potential for secondary malignancies due to mutagenesisOff-target effects on normal tissue DNA

Interacting drugs

Ionizing Radiation

Beyond the preview

Go deeper on Tumor Cell Genomic DNA (DNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tumor Cell Genomic DNA (DNA).

Explore the full profile